HONG KONG, Jan. 22, 2025 /PRNewswire/ — On January 22, 2025, Akeso Inc. (9926.HK) announced that it had received payment from Sichuan Kelun Pharmaceutical Research Institute Co., Ltd. (“Sichuan Kelun”) for their collaboration on the development of tagitanlimab, an innovative humanized…